Oxford Ebola Vaccine: What to Know About the New Shot Entering Human Trials
Oxford has launched the first human trial of a vaccine targeting the Bundibugyo strain of Ebola, as the death toll in the Democratic Republic of Congo's outbreak passes 700 with no existing vaccine…
Read the full articleYou might also wanna read
Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate efforts to co
Oxford begins first human trial of Bundibugyo Ebola vaccine
July 13 (Reuters) - The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accel
Oxford, Serum Institute Launch First Human Trial for New Ebola Vaccine
Oxford and Serum Institute have launched the first human trial of a vaccine targeting the deadly Bundibugyo strain of Ebola virus.
UK Begins Human Trials of New Ebola Vaccine in Just 57 Days as Scientists Race to Stop Deadly Virus
Oxford University has initiated human trials for a new Ebola vaccine just 57 days after development, targeting the Bundibugyo strain amid an
UK Begins Human Trials of New Ebola Vaccine in Just 57 Days as Scientists Race to Stop Deadly Virus
Oxford University has initiated human trials for a new Ebola vaccine just 57 days after development, targeting the Bundibugyo strain amid an
Vaccine trial launched in Oxford in response to deadly outbreak
A vaccine trial is under way as part of efforts to tackle the Bundibugyo ebolavirus.
Comments
Sign in to join the conversation.
No comments yet. Be the first.